FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology

January 19, 2021 - The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments, Inc. (Seno) premarket approval (PMA) for its groundbreaking diagnostic breast cancer imaging technology that helps physicians better differentiate between benign and malignant breast lesions. The company’s Imagio® Breast Imaging [...]

2021-02-02T20:01:52+00:00 January 20th, 2021|Comments Off on FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology